MD2473G2 - Method of correction of the cardiac rhythm variability - Google Patents

Method of correction of the cardiac rhythm variability Download PDF

Info

Publication number
MD2473G2
MD2473G2 MDA20030037A MD20030037A MD2473G2 MD 2473 G2 MD2473 G2 MD 2473G2 MD A20030037 A MDA20030037 A MD A20030037A MD 20030037 A MD20030037 A MD 20030037A MD 2473 G2 MD2473 G2 MD 2473G2
Authority
MD
Moldova
Prior art keywords
correction
cardiac rhythm
rhythm variability
variability
cardiotropic
Prior art date
Application number
MDA20030037A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2473F1 (en
Inventor
Михаил ПОПОВИЧ
Валериу КОБЕЦ
Валериу РУДИК
Анатол МАЛКОЧ
Александру РОБУ
Михаил ТОДИРАШ
Ион ПОПОВИЧ
Ион МОРАРУ
Original Assignee
Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова filed Critical Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority to MDA20030037A priority Critical patent/MD2473G2/en
Publication of MD2473F1 publication Critical patent/MD2473F1/en
Publication of MD2473G2 publication Critical patent/MD2473G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention refers to medicine, namely to cardiology.Summary of the method consists in the administration of the preparation on base of extract from Spirulina platensis CNM-CB-02(BioR) cyanobacteria strain biomass in the dose of 1,05 mg/kg with the speed of 0,07 mg/kg/min in the capacity of cardiotropic remedy.
MDA20030037A 2003-01-31 2003-01-31 Method of correction of the cardiac rhythm variability MD2473G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030037A MD2473G2 (en) 2003-01-31 2003-01-31 Method of correction of the cardiac rhythm variability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030037A MD2473G2 (en) 2003-01-31 2003-01-31 Method of correction of the cardiac rhythm variability

Publications (2)

Publication Number Publication Date
MD2473F1 MD2473F1 (en) 2004-06-30
MD2473G2 true MD2473G2 (en) 2005-02-28

Family

ID=32677960

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030037A MD2473G2 (en) 2003-01-31 2003-01-31 Method of correction of the cardiac rhythm variability

Country Status (1)

Country Link
MD (1) MD2473G2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008016C1 (en) * 1988-09-23 1994-02-28 Рудик Валерий Филиппович Experimental heart stimulant
MD545F1 (en) * 1995-05-10 1996-05-31 Valeriu Rudic Medical preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008016C1 (en) * 1988-09-23 1994-02-28 Рудик Валерий Филиппович Experimental heart stimulant
MD545F1 (en) * 1995-05-10 1996-05-31 Valeriu Rudic Medical preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Azuma J. The heart failure research with taurine group. Long-term effect of taurine in congestive heart failure> preliminary report.// In> Taurine in health and diseases. Eds by Huxtable RJ, and Michalk D., New-York, 1994, p. 425…435 *

Also Published As

Publication number Publication date
MD2473F1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
UA104634C2 (en) PEGYLOVAN L-ASPARAGINASE $PEGYLATED L-ASPARAGINASE
EP4389213A3 (en) Treatment of fabry disease in ert-naive and ert-experienced patients
NO20070979L (en) Use of N-aryldiazaspiracyclic compounds in the treatment of addiction
EP4316589A3 (en) Treatment of patients with classic fabry disease
NO20082672L (en) Use of cycletanine and other fluoropyridines for the treatment of systolic-dominant hypertension, isolated hypertension, increased pulse pressure and general hypertension
NO20080244L (en) Dosage control for prasugrel
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
EA200100568A1 (en) PHARMACEUTICAL COMPOSITIONS IN CAPSULES FROM HYDROXYPROPYLMETHIL CELLULOSE
MX2021000349A (en) Administration of sumo-activating enzyme inhibitor and anti-cd20 antibodies.
EA200700158A1 (en) MEDICAL FORMS WITH A TABLET NUCLEUS, COVERED WITH THE ENTEROROLEUBLISHING SHELL
PL1727817T3 (en) Azabicyclooctan-3-one derivatives and use thereof
ZA200502790B (en) Extract with anti-tumor and anti-poisonous activity.
MD2473F1 (en) Method of correction of the cardiac rhythm variability
EP1902712A4 (en) Use of levo-ornidazole for preparing antiparasitic infection drug
MY127452A (en) Vaccines.
MD2211F1 (en) Remedy for treatment of parodontium affections
MD2355F1 (en) Method of preimplanting preparation
NO20075508L (en) Stable Soporphine Preparations and Administration
MD3226G2 (en) Process for spermatogenesis optimization to bulls-reproducers
SG152285A1 (en) Solid pharmaceutical formulation
MD2210F1 (en) Method of treatment of parodontitis
MD1854G2 (en) Method of treatment in the congestive cardiac insufficiency
WO2005044999A3 (en) Treatment with immunoregulatory t cells
MD20050038A (en) Process for immunocorrection of organism natural resistance
MD20050040A (en) Method of normalizing the functional activity of lymphocytes

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees